Holders over time
- DGX
- ELV
| Quarter | DGX | ELV |
|---|---|---|
| Q3 2020 | 18 holders, $1.0bn | 30 holders, $15.0bn |
| Q4 2020 | 21 holders, $1.1bn | 29 holders, $16.7bn |
| Q1 2021 | 19 holders, $1.2bn | 25 holders, $18.6bn |
| Q2 2021 | 14 holders, $975m | 30 holders, $19.4bn |
| Q3 2021 | 17 holders, $1.1bn | 26 holders, $18.5bn |
| Q4 2021 | 17 holders, $1.5bn | 29 holders, $23.3bn |
| Q1 2022 | 16 holders, $812m | 31 holders, $23.9bn |
| Q2 2022 | 16 holders, $813m | 32 holders, $23.3bn |
| Q3 2022 | 16 holders, $910m | 34 holders, $22.6bn |
| Q4 2022 | 13 holders, $1.1bn | 34 holders, $25.5bn |
| Q1 2023 | 17 holders, $989m | 39 holders, $22.5bn |
| Q2 2023 | 16 holders, $1.3bn | 38 holders, $20.6bn |
| Q3 2023 | 15 holders, $1.1bn | 34 holders, $19.8bn |
| Q4 2023 | 11 holders, $1.2bn | 36 holders, $20.3bn |
| Q1 2024 | 10 holders, $777m | 35 holders, $21.3bn |
| Q2 2024 | 13 holders, $1.2bn | 33 holders, $22.1bn |
| Q3 2024 | 11 holders, $1.7bn | 30 holders, $20.2bn |
| Q4 2024 | 9 holders, $1.6bn | 32 holders, $15.9bn |
| Q1 2025 | 10 holders, $1.8bn | 28 holders, $17.1bn |
| Q2 2025 | 10 holders, $2.4bn | 27 holders, $14.8bn |
| Q3 2025 | 13 holders, $2.5bn | 27 holders, $12.7bn |
| Q4 2025 | 10 holders, $1.5bn | 25 holders, $17.0bn |
| Q1 2026 | 9 holders, $1.6bn | 26 holders, $13.6bn |
| Q2 2026 | 7 holders, $1.6bn | 28 holders, $17.7bn |
Quest Diagnostics Inc
- Holders
- 13
- Reported value
- $1.2bn
- Buyers
- 9
- Sellers
- 4
Breadth +5 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 33
- Reported value
- $22.1bn
- Buyers
- 14
- Sellers
- 21
Breadth -7 among 94 comparable managers.
Who holds both, Q2 2024
Both (11)
Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Invesco Ltd, Man Group PLC, Marshall Wace LLP, Millennium Management LLC, Point72 Asset Management LP, Wellington Management Group LLP
Only DGX (2)
Only ELV (22)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Glenview Capital Management LLC, Holocene Advisors LP, Jane Street Group LLC, Janus Henderson Group Ltd, MFS Investment Management, Moore Capital Management LP, Neuberger Berman Group LLC, Ruane Cunniff & Goldfarb LP, T. Rowe Price Associates Inc, Two Sigma Investments LP, Voloridge Investment Management LLC, Winton Group Ltd
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.